fundvisualizer.com

BNY Mellon International Stock Index InvDIISX

Performance (before sales charge)

As of 08/31/2024

All information is historical and not indicative of future results. Current performance may be lower or higher than the quoted past performance, which cannot guarantee results. Share price, principal value, and return will vary, and you may have a gain or a loss when you sell your shares. Performance assumes reinvestment of distributions and does not account for taxes. After-sales-charge returns reflect the maximum sales charge applicable to the fund. Performance may not reflect any expense limitation or subsidies currently in effect. Short-term trading fees may apply. To obtain the most recent month-end performance, visit Morningstar.com.

Asset allocation

As of 07/31/2024
Stock
0.66%
Non-U.S. Stock
97.11%
Bond
0.00%
Non-U.S. Bond
0.00%
Preferred
0.00%
Convertible
0.00%
Cash
2.00%
Other
0.22%

Due to rounding, percentages may not equal 100%.

Sectors

As of 07/31/2024

Basic materials

6.36%

Consumer cyclical

9.70%

Financial services

19.08%

Real estate

2.15%

Consumer defensive

8.06%

Health care

13.32%

Utilities

2.95%

Communication services

4.41%

Energy

3.90%

Industrials

16.09%

Technology

9.48%

Top 10 holdings

As of 07/31/2024

Novo Nordisk A/S Class B
2.44%
Msci Eafe Sep19
2.28%
ASML Holding NV
2.07%
Dreyfus Instl Preferred Gov Plus MMkt
2.00%
Nestle SA
1.53%
AstraZeneca PLC
1.38%
Shell PLC
1.32%
Roche Holding AG
1.28%
Novartis AG Registered Shares
1.24%
SAP SE
1.24%
Fund assets

$344.58 Million

Share class

Inv

Morningstar category

Foreign Large Blend

Expense ratio

0.60%

Investment objective

Foreign Stock

Documents